Jump Trading’s Abiomed Inc ABMD Stock Holding History

Jump Trading’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-767	Closed	-$219K	–	639
2019 Q1	$219K	Buy	+767	New	+$255K	0.07%	310

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Jump Trading's ABMD Position: Q2 2019 in Review

Jump Trading sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 767 shares — an estimated $219K sold.

Jump Trading first reported a position in ABMD in Q1 2019 and held it in 1 quarter. The position peaked at $219K in Q1 2019. 483 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

Jump Trading reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 767 Abiomed Inc shares in Q2 2019, an estimated $219K.
Jump Trading first reported a position in Abiomed Inc in Q1 2019 and held it in 1 quarter.
Jump Trading's Abiomed Inc position peaked at $219K in Q1 2019.
483 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.